NIH-funded study finds GLP-1 drugs slow aging in mice, adding independent evidence to drug companies' aging-clock claims

An NIH-funded study found that GLP-1 drugs slow aging in mice, boosting the outlook for Novo Nordisk and Eli Lilly, the leading makers of the drugs.

Detected & updated continuously · Source: Nebula